TORONTO, Jan. 18, 2019 /CNW/ - Simon Langelier, Chairman of the Board, PharmaCielo Ltd. (PCLO), joined Tim Babcock, Managing Director, Capital Formation, TSX Venture Exchange, to open the market. PharmaCielo is headquartered in Canada, with a focus on processing and supplying medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal, and wholly owned subsidiary is PharmaCielo Holdings, headquartered at its nursery and propagation centre located in Rionegro, Colombia. PharmaCielo Ltd. commenced trading on TSX Venture Exchange on January 18, 2019.
SOURCE TMX Group Limited
